Operating income, growth figures, profitability and how our products have behaved.
Tue, 20/02/2018 - 12:50
1 minOperating income, growth figures, profitability and how our products have behaved.
Related
The operating revenue of Laboratorios Farmacéuticos ROVI increased by 10% to 303.2 million euros in 2018, driven mainly by the strength of...
5 min
26/02/2019
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has reached an agreement with a subsidiary of MSD (“MSD”) whereby ROVI acquires certain...
2 min
15/02/2019
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the purchase of Falithrom®, which was owned by Hexal AG (“Hexal”), a company...
1 min
09/01/2019
IMG_7413(2).jpg
Operating income, growth figures, profitability and how our products have behaved.